6051 results for "canc*"
in 45.43 milliseconds.
-
UT MD Anderson Cancer Center Department of Genomic Medicine Lipoasarcoma Data Access Committee
Dac EGAC00001000821 -
Peter Mac Translational Breast Cancer Genomics and Therapeutics Lab Data Access Committee
Dac EGAC00001000837 -
MCCB Breast Cancer Data Access Committee
Dac EGAC00001000854 -
Breast cancer multi-region sequencing from Sottoriva Lab
Dac EGAC00001000890 -
Spatial Maps of Prostate Cancer Transcriptomes Data Access
Dac EGAC00001000913 -
The evolutionary history of human colitis-associated colorectal cancer
Dac EGAC00001000917 -
Harbin Medical University Cancer Hospital Data Access Commitee
Dac EGAC00001000948 -
Division of Cancer Genomics, National Cancer Center Research Institute Data Access Committee
Dac EGAC00001000957 -
DAC for study: Frequent mutation of the FOXA1 untranslated region in prostate cancer
Dac EGAC00001000962 -
Ludwig Data Access Committee for the Study of Oesophageal Cancer
Dac EGAC00001000978 -
DAC for CancerDetector study
Dac EGAC00001000979 -
The University of Hong Kong Gastric Cancer Organoids Genomics Study Data Access Committee
Dac EGAC00001000981 -
Stanford Data Access Committee for Breast Cancer Tumor Heterogeneity through Treatment
Dac EGAC00001000993 -
Colorectal Cancer Organoids Data Access Committee
Dac EGAC00001000998 -
Genome-wide association study of cervical cancer in East Asian populations
Dac EGAC00001001024 -
Data Access Commitee for gastric cancer ascites
Dac EGAC00001001026 -
Rectal Cancer Samples Data Access Committee
Dac EGAC00001001034 -
University of Florida Brain Cancer DAC
Dac EGAC00001001035 -
University Clinic Erlangen/ German Cancer Research Center rare tumors data access committee
Dac EGAC00001001053 -
Age-related remodeling of apparently normal esophageal epithelia by common cancer drivers
Dac EGAC00001001067 -
SNP array datas of "Matched" cancer/PNE
Dac EGAC00001001069 -
DAC for study: Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer
Dac EGAC00001001082 -
DAC for Familial Breast Cancer study EGAS00001003305
Dac EGAC00001001087 -
DAC for study Non-coding RNAs in Breast Cancer
Dac EGAC00001001090 -
DAC for study: "Circulating tumour DNA abundance and potential utility in de novo metastatic prostate cancer"
Dac EGAC00001001099 -
DAC for Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Dac EGAC00001001101 -
Radboudumc Cancer Genomics DAC
Dac EGAC00001001102 -
DAC for MCO colorectal cancer genomics at UNSW
Dac EGAC00001001122 -
DAC for Genomic characterization of metastatic breast cancers
Dac EGAC00001001129 -
Korean Advanced Thyroid Cancer Data Access Commitee
Dac EGAC00001001151 -
DAC for GAMuT Project - Peter MacCallum Cancer Centre
Dac EGAC00001001154 -
Leeds Cancer Genomics
Dac EGAC00001001156 -
Children's Cancer Therapy Development Institute Data Access Commitee
Dac EGAC00001001160 -
Stanford Data Access Committee for Multi-Region WES of Metastatic Colorectal Cancer
Dac EGAC00001001164 -
Charbonneau Cancer Institute DAC
Dac EGAC00001001165 -
The data access committee for genome-wide cell-free DNA fragmentation in patients with cancer
Dac EGAC00001001180 -
OSBREAC (Oslo Breast Cancer Research Consortium)
Dac EGAC00001001186 -
Latency and interval therapy affect the evolution in metastatic colorectal cancer.
Dac EGAC00001001198 -
Gastric Cancer Pan-genome Data Access Commitee
Dac EGAC00001001211 -
Immune and Metabolic Features of Brain Metastases Melanoma (Cancer Discovery) Data Access Committee
Dac EGAC00001001216 -
Ewha-Samsumg Lung cancer collaboration DAC
Dac EGAC00001001237 -
DAC for Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness
Dac EGAC00001001250 -
UT MD Anderson Cancer Center Genomic Medicine and Leukemia
Dac EGAC00001001252 -
Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee
Dac EGAC00001001272 -
SMC Colon cancer team
Dac EGAC00001001277 -
DAC for GAMuT Project - Peter MacCallum Cancer Centre
Dac EGAC00001001278 -
Charbonneau Cancer Institute DAC
Dac EGAC00001001280 -
Ewha-Samsung Lung cancer collaboration DAC
Dac EGAC00001001283 -
ASAN Center for Cancer Genome Discovery Data Access Commitee
Dac EGAC00001001285 -
High-grade serous ovarian cancer (MDACC) data access committee
Dac EGAC00001001288 -
DAC for HSTCL study. National Cancer Centre Singapore.
Dac EGAC00001001302 -
DAC for Angiosarcoma Study. National Cancer Centre Singapore.
Dac EGAC00001001311 -
DAC for MEITL study. National Cancer Centre Singapore.
Dac EGAC00001001323 -
The data access committee for Multimodal Genomic Features Predict Outcome of Immune Checkpoint Blockade in Non-small Cell Lung Cancer
Dac EGAC00001001331 -
UCL Cancer Institute Data Access Committee
Dac EGAC00001001360 -
ASAN Center for Cancer Genome Discovery Data Access Commitee
Dac EGAC00001001391 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001001404 -
The University of Hong Kong Colon Cancer Organoids Genomics Study Data Access Committee
Dac EGAC00001001405 -
Cancer Sequencing Data Access Committee
Dac EGAC00001001428 -
Data access committee for white blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Dac EGAC00001001435 -
Cancer Data Access Commitee
Dac EGAC00001001436 -
Yale Cancer Center Data Access Commitee
Dac EGAC00001001437 -
Hyperpolarized 13C MRI in breast cancer DAC
Dac EGAC00001001438 -
Prostate Cancer Biobank Insbruck DAC
Dac EGAC00001001463 -
Metastases of a cancer of unknown primary (CUP)
Dac EGAC00001001484 -
Single Cell RNAseq of blood and tumor from renal cancer patients
Dac EGAC00001001494 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001001500 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001001505 -
The data usage policy for epigenomic profile of diverse cancer
Dac EGAC00001001540 -
Hereditary Cancer Diagnostics with I2HCP Data Access Comitee
Dac EGAC00001001541 -
Breast cancer bone metastases
Dac EGAC00001001548 -
Inherited Predisposition to Cancer Projects Data Access Committee
Dac EGAC00001001565 -
DAC for Phylogenetic reconstruction of breast cancer
Dac EGAC00001001572 -
Children's Cancer Therapy Development Institute DAC
Dac EGAC00001001581 -
Nicola Murray Centre for Ovarian Cancer Research Data Access Committee
Dac EGAC00001001588 -
DAC Barretos Cancer Hospital
Dac EGAC00001001592 -
Immunogenomics of Colorectal Cancer Data Access Committee
Dac EGAC00001001596 -
UZ Ghent Prostate Cancer Team Data Access Committee
Dac EGAC00001001608 -
Mutational Study Committee of a Taiwanese Lung Cancer Cohort (MSCTLCC)
Dac EGAC00001001614 -
Data access policy for PDTX Breast Cancer RNA-seq data from Ros et al (2020)
Dac EGAC00001001620 -
Data Access Committee of divisions B060 and B062, German Cancer Research Center (DKFZ)
Dac EGAC00001001626 -
Cancer Clinical Research Trust DAC for WES of HER2+ metastatic cancer samples
Dac EGAC00001001632 -
Primary tumor and metastatic breast cancer data access
Dac EGAC00001001687 -
Cancer Alliance Data Access Committee
Dac EGAC00001001641 -
INSERM U981 Team : Genomics of Non-Melanoma Skin Cancer
Dac EGAC00001001644 -
Princess Margaret Head and Neck Cancer Data Access Committee
Dac EGAC00001001647 -
NKI (Netherlands Cancer Institute)
Dac EGAC00001001648 -
Spatial Characterization Breast Cancer
Dac EGAC00001001673 -
Zero Childhood Cancer
Dac EGAC00001001683 -
DAC for Stuttgart Breast Cancer Cohort
Dac EGAC00001001693 -
Detection of ctDNA in Plasma of Patients with Clinically Localised Prostate Cancer is Associated with Rapid Disease Progression
Dac EGAC00001001718 -
Gene expression and Cancer
Dac EGAC00001001727 -
MyBrCa Tumour Genomics DAC
Dac EGAC00001001740 -
Lung cancer TRM Data Access Commitee
Dac EGAC00001001759 -
Cancer Research UK manchester Institute Cancer Biomarker Centre
Dac EGAC00001001765 -
Gene expression and Cancer
Dac EGAC00001001772 -
Data Access Commitee of Nanjing Medical University Affiliated Jiangsu Cancer Hospital
Dac EGAC00001001774 -
Access to aligned sequencing data for study "Loss of SNAI2 in prostate cancer correlates with clinical response to androgen deprivation therapy".
Dac EGAC00001001809 -
Imperial College Tumour Immunology group - Surgery and Cancer DAC
Dac EGAC00001001814 -
Long-read isoform in breast cancer - Data Access Commitee
Dac EGAC00001001821